pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia, Mastocytosis, Mast cell activation syndrome, Multiple Scleros
PARIS, FR HQ
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB20006
Phase 2 · small molecule · Mast cell activation syndrome
AB20006 for Mast cell activation syndrome is a Phase 2 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Internal code AB20006
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AB Science
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Mast cell activation syndrome
- Status
- active
- Trials
- 1